Search Results - "Luo, Suxia"

Regulation of PD-L1 expression in the tumor microenvironment by Yi, Ming, Niu, Mengke, Xu, Linping, Luo, Suxia, Wu, Kongming

“…Programmed death-ligand 1 (PD-L1) on cancer cells engages with programmed cell death-1 (PD-1) on immune cells, contributing to cancer immune escape. For…”
Get full text

Immune signature-based risk stratification and prediction of immune checkpoint inhibitor’s efficacy for lung adenocarcinoma by Yi, Ming, Li, Anping, Zhou, Linghui, Chu, Qian, Luo, Suxia, Wu, Kongming

“…Background Lung adenocarcinoma (LUAD) is a common pulmonary malignant disease with a poor prognosis. There were limited studies investigating the influences of…”
Get full text

Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4 by Qin, Shuang, Xu, Linping, Yi, Ming, Yu, Shengnan, Wu, Kongming, Luo, Suxia

“…The emergence of immune checkpoint inhibitors (ICIs), mainly including anti-programmed cell death protein 1/programmed cell death ligand 1 (PD-1/PD-L1) and…”
Get full text

The role of exosomes in liquid biopsy for cancer diagnosis and prognosis prediction by Li, Shiyu, Yi, Ming, Dong, Bing, Tan, Ximin, Luo, Suxia, Wu, Kongming

“…Liquid biopsy is a revolutionary strategy in cancer diagnosis and prognosis prediction, which is used to analyze cancer cells or cancer‐derived products…”
Get full text

The role of cancer-derived microRNAs in cancer immune escape by Yi, Ming, Xu, Linping, Jiao, Ying, Luo, Suxia, Li, Anping, Wu, Kongming

“…During malignant transformation, accumulated somatic mutations endow cancer cells with increased invasiveness and immunogenicity. Under selective pressure,…”
Get full text

Vitexin induces apoptosis through mitochondrial pathway and PI3K/Akt/mTOR signaling in human non-small cell lung cancer A549 cells by Liu, Xiaoli, Jiang, Qingfeng, Liu, Huaimin, Luo, Suxia

“…Currently, the prognosis of patients with non-small cell lung cancer (NSCLC) remains dismal; hence, it is critical to identify effective anti-NSCLC agents with…”
Get full text

ASO Author Reflections: Impact of Ipsilateral Supraclavicular Lymph Node Dissection on Breast Cancer by Lv, Minhao, Luo, Suxia

Get full text

The construction, expression, and enhanced anti-tumor activity of YM101: a bispecific antibody simultaneously targeting TGF-β and PD-L1 by Yi, Ming, Zhang, Jing, Li, Anping, Niu, Mengke, Yan, Yongxiang, Jiao, Ying, Luo, Suxia, Zhou, Pengfei, Wu, Kongming

“…Therapeutic antibodies targeting programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) axis induce potent and durable anti-tumor responses…”
Get full text

Prospects for combining immune checkpoint blockade with PARP inhibition by Li, Anping, Yi, Ming, Qin, Shuang, Chu, Qian, Luo, Suxia, Wu, Kongming

“…The immunogenicity of a cancer cell is derived from accumulated somatic mutations. However, on the contrary to increased immunogenicity, anti-cancer immune…”
Get full text

Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC by Niu, Mengke, Yi, Ming, Li, Ning, Luo, Suxia, Wu, Kongming

“…Immunotherapy, especially anti-programmed cell death protein 1/programmed cell death ligand 1 (PD-1/PD-L1) treatment has significantly improved the survival of…”
Get full text

Epidemiological trends of women’s cancers from 1990 to 2019 at the global, regional, and national levels: a population-based study by Yi, Ming, Li, Tianye, Niu, Mengke, Luo, Suxia, Chu, Qian, Wu, Kongming

“…Abstract Background Every year around the world, more than 2 million women are diagnosed with breast cancer and genital tract cancers. However, there are rare…”
Get full text

Oxaliplatin-induced upregulation of exosomal miR-424-3p derived from human bone marrow mesenchymal stem cells attenuates progression of gastric cancer cells by Shen, Wei, Wei, Chen, Li, Ning, Yu, Wenyue, Yang, Xinyi, Luo, Suxia

“…Chemotherapy, particularly with oxaliplatin, is a key treatment for advanced gastric cancer (GC), and exosomes derived from human bone marrow mesenchymal stem…”
Get full text

Advances and perspectives of PARP inhibitors by Yi, Ming, Dong, Bing, Qin, Shuang, Chu, Qian, Wu, Kongming, Luo, Suxia

“…Abstract DNA damage repair deficiency leads to the increased risk of genome instability and oncogenic transformation. In the meanwhile, this deficiency could…”
Get full text

MiRNA-mediated EMT and CSCs in cancer chemoresistance by Dong, Bing, Li, Shiyu, Zhu, Shuangli, Yi, Ming, Luo, Suxia, Wu, Kongming

“…Cancer stem cells (CSCs) are a small group of cancer cells, which contribute to tumorigenesis and cancer progression. Cancer cells undergoing…”
Get full text

MiR-645 promotes invasiveness, metastasis and tumor growth in colorectal cancer by targeting EFNA5 by Li, Shuai, Hou, Xinfang, Wu, Chen, Han, Lili, Li, Qian, Wang, Jufeng, Luo, Suxia

“…•MiR-645 promotes CRC cell migration and invasion in vitro and in vivo.•MiR-645 stimulates the EMT of CRC cells.•EFNA5 mRNA is a direct target of…”
Get full text

Impact of Ipsilateral Supraclavicular Lymph Node Dissection (ISLND) for Breast Cancer Patients and a Nomogram for Predicting Ipsilateral Supraclavicular Pathological Complete Response (ispCR) by Lv, Minhao, Li, Juntao, Guo, Huihui, Wang, Chao, Tian, Peiqi, Ma, Youzhao, Chen, Xiuchun, Luo, Suxia

“…Background The purpose of this study was to evaluate the impact of ipsilateral supraclavicular lymph node dissection (ISLND) on the outcomes of breast cancer…”
Get full text

The roles of exosomes in cancer drug resistance and its therapeutic application by Li, Shiyu, Yi, Ming, Dong, Bing, Jiao, Ying, Luo, Suxia, Wu, Kongming

“…Exosomes are a category of extracellular vesicles with a size ranging from 40 to 160 nm, which can be secreted by multiple cells in the tumor microenvironment…”
Get full text

Impact of perioperative hemoglobin-related parameters on clinical outcomes in patients with spinal metastases: identifying key markers for blood management by Li, Zhehuang, Yao, Weitao, Wang, Jiaqiang, Wang, Xin, Luo, Suxia, Zhang, Peng

“…Patients with spinal metastases undergoing surgical treatment face challenges related to preoperative anemia, intraoperative blood loss, and frailty,…”
Get full text

Prognostic impact of examined lymph-node count for patients with esophageal cancer: development and validation prediction model by Yuan, Shasha, Wei, Chen, Wang, Mengyu, Deng, Wenying, Zhang, Chi, Li, Ning, Luo, Suxia

“…Esophageal cancer (EC) is a malignant tumor with high mortality. We aimed to find the optimal examined lymph node (ELN) count threshold and develop a model to…”
Get full text

PHF5A facilitates the development and progression of gastric cancer through SKP2-mediated stabilization of FOS by Zhang, Zhandong, Peng, Liangqun, Yang, Wei, Li, Baodong, Hua, Yawei, Luo, Suxia

“…Gastric cancer (GC) is the fifth most common cancer and the third most common cause of cancer death worldwide. Plant homeodomain (PHD)-finger domain protein…”
Get full text